Projects

doc. Mgr. Andrea Šoltýsová, PhD.

International

Current
  • Reversing Epitranscriptomic Alterations for CHemosensitization of Pancreatic Cancer
    Program: ERANET
    Duration: 1. 9. 2024 – 31. 8. 2027
Finished
  • Epigenotoxicity of nanomaterials
    Program: Inter-academic agreement
    Duration: 1. 1. 2020 – 31. 12. 2022
  • FP7 Health: Clinical Development of Nitisinone for Alkaptonuria
    Program: FP7
    Duration: 1. 11. 2012 – 31. 1. 2019

National

Current
  • Innovative approaches to the diagnosis and treatment of pancreatic ductal adenocarcinoma
    Program:
    Duration: 1. 9. 2024 – 30. 6. 2026
Finished
  • Suicide gene therapy mediated by mesenchymal stromal and pancreatic tumor cell-excreted extracellular vesicles in the treatment of pancreatic ductal adenocarcinoma
    Program: SRDA
    Duration: 1. 7. 2021 – 30. 6. 2025
  • TArgetiNg Dna mEthylation by epigenetic editing and its implementation into personalised diagnostics and therapy of uveal Melanoma
    Program: SRDA
    Duration: 1. 8. 2018 – 31. 12. 2022
  • Study of the genetic background of variable severity of Alkaptonuria using genomic approach.
    Program: VEGA
    Duration: 1. 1. 2020 – 31. 12. 2022
  • Implementation of modern genomic analyzes to improve clinical diagnostic and therapeutic procedures of Immune Disorders
    Program: Other projects
    Duration: 1. 12. 2018 – 31. 12. 2020
  • Study of the potential role of selected genes in molecular pathogenesis of myotonic dystrophy
    Program: VEGA
    Duration: 1. 1. 2015 – 31. 12. 2017
Employees